Tim Wentworth At Walgreens: CEO Compensation & Career Insights

08 May, 2025

Can a single executive truly steer a pharmaceutical behemoth through turbulent times? Timothy Wentworth, the current CEO of Walgreens Boots Alliance (WBA), is tasked with navigating this very challenge, a role that comes with significant responsibility and, as well explore, substantial compensation.

In the volatile world of healthcare and retail, where market forces shift and consumer behaviors evolve, the appointment of a new Chief Executive Officer often signals a pivotal moment for a company. For Walgreens Boots Alliance, the arrival of Tim Wentworth in October 2023 marked such a juncture. With the drugstore giant facing the complexities of a changing landscape, from shifting consumer habits to the ever-present pressures of the healthcare industry, the expectations placed upon Wentworth are considerable. The company, after reporting a net income of $344 million in its third quarter, is actively pursuing a strategic plan, a journey where patience, as Wentworth himself has requested, is paramount. This transition places Wentworth at the helm, entrusted with the task of steering Walgreens towards future success.

Category	Details
Full Name	Timothy C. Wentworth
Date of Birth	1959/1960 (Age: 64 years old)
Nationality	American
Current Position	Chief Executive Officer, Walgreens Boots Alliance (WBA)
Tenure at WBA	Appointed October 2023 (1.5 years)
Previous Positions	Former CEO, Evernorth (Cigna's health services platform) Former CEO, Express Scripts (Pharmacy Benefit Manager)
Education	Information Not Available
Total Compensation (Most Recent)	$13,282,800 (as chief executive officer at Walgreens Boots Alliance Inc)
Direct Stock Ownership	0.015% of the company\u2019s shares, worth $1.47m
Initial Base Salary	$1,500,000
Base Salary (2023)	$1.5 million
Annual Bonus	Eligible with a target payout of 200%
Source	Walgreens Boots Alliance Official Website

Wentworth's professional journey prior to Walgreens is a testament to his deep-rooted experience in the healthcare sector. Before taking the reins at WBA, he served as the CEO of Evernorth, Cigna's health services platform. This role saw him lead an organization that partners with health plans, employers, and governmental bodies, showcasing his expertise in a broad spectrum of healthcare services. Prior to his time at Cigna, Wentworth held the position of CEO at Express Scripts, the largest pharmacy benefit manager in the United States. His leadership there demonstrates his proficiency in navigating the intricate complexities of pharmaceutical benefits management and the broader healthcare system. Express Scripts was later acquired by Cigna in 2018, a move that highlighted Wentworth's significant impact and influence within the industry. This experience positioned him well to step into the leadership role at Walgreens.

The financial aspects of Wentworth's leadership at WBA are as noteworthy as his professional background. In the role of chief executive officer, Wentworth's total compensation package has been significant, reaching $13,282,800. This compensation model is multi-faceted, composed of a base salary, bonuses, and potentially, company stock and options. The specifics of this compensation structure, including the proportions allocated to salary versus bonuses, fluctuate. For instance, in 2023, Wentworths total compensation was primarily composed of his base salary, $1.5 million, as he did not receive additional bonuses or equity awards due to the company's financial performance not meeting predetermined targets. In another instance the total yearly compensation is $13.50m, comprised of 9.6% salary and 90.4% bonuses, including company stock and options.

The appointment of Wentworth also signaled a changing of the guard, with Rosalind Brewer's departure paving the way for his arrival. This transition underscored the company's strategic goals, seeking a leader who could leverage their deep understanding of healthcare and the pharmacy sector. The choice of Wentworth, with nearly three decades of healthcare leadership under his belt, reflects Walgreens' strategic vision for the future. His wealth of knowledge and experience is expected to guide Walgreens through its challenges and capitalize on opportunities within the evolving healthcare landscape. His previous roles at Evernorth and Express Scripts have given him insight into the intricacies of the industry, allowing him to strategically guide the company's trajectory.

The timing of Wentworth's appointment, in October 2023, coincides with a period of transformation for the company. He also joined the WBA board of directors upon assuming the role, further solidifying his position as a key decision-maker. His initial annualized base salary was set at $1,500,000, and he is eligible for an annual bonus, demonstrating the company's commitment to aligning his interests with its success.

The scale of WBA's operations and its position within the pharmaceutical industry adds layers of complexity to Wentworth's role. With thousands of stores globally and a wide range of services, from dispensing medications to providing healthcare services, WBA holds a significant place in the everyday lives of millions. Managing such a large and diverse enterprise necessitates a deep understanding of retail, healthcare, and consumer behavior. The companys efforts to adapt to changing market dynamics, including the growth of online pharmacies and evolving consumer preferences, underscore the need for innovative leadership.

The challenges before Wentworth and WBA are significant. Convincing stakeholders, including investors, employees, and customers, of the company's path forward requires transparency, strategic vision, and consistent execution. The healthcare industry is in constant flux, marked by technological advancements, shifting regulatory frameworks, and ever-changing consumer demands. Wentworth's prior experience at Express Scripts and Evernorth likely equips him with the insights and strategies required to navigate these obstacles and to seize opportunities for growth. The ability to navigate the complexities of the healthcare system, address evolving consumer expectations, and adapt to the challenges and opportunities that come with the changing industry landscape remains vital.

The strategic direction of Walgreens Boots Alliance under Tim Wentworth's leadership will be crucial to its future. His plan is focused on innovation and growth. The company's ability to compete effectively in a crowded market, to adapt to emerging trends, and to enhance its value proposition will be critical. The success of these endeavors will be a measure of Wentworth's leadership and his ability to execute his strategic vision.

In conclusion, the appointment of Tim Wentworth as CEO of Walgreens Boots Alliance is a pivotal moment for the company. His extensive background in the healthcare industry, coupled with the scale of the task before him, positions his tenure as one to watch. The decisions he makes and the strategies he implements will have a profound impact on the company's trajectory and on the wider healthcare landscape. The future of Walgreens, and perhaps the very direction of the retail pharmacy sector, may well be shaped by the actions of Tim Wentworth.

Who is Tim Wentworth, Walgreens' new CEO? Crain's Chicago Business

Details

10 Things You Didn't Know About Express Scripts CEO Tim Wentworth

Details

[Business] Walgreens names veteran health care executive Tim

Details

Detail Author:

Name : Taurean Pfannerstill
Username : billy87
Email : zoila81@yahoo.com
Birthdate : 1985-10-03
Address : 7664 Edgar Port Apt. 747 Volkmanport, IL 78907
Phone : +1-618-451-2716
Company : Carroll and Sons
Job : Janitor
Bio : Excepturi nesciunt voluptas qui dolore. Eaque vero magni provident et qui unde quam. Vitae nobis corrupti voluptates delectus rem et occaecati.

Socials

facebook:

url : https://facebook.com/adamwuckert
username : adamwuckert
bio : Aut necessitatibus et animi facilis esse vitae quia.
followers : 2848
following : 2063

twitter:

url : https://twitter.com/wuckert2016
username : wuckert2016
bio : Occaecati ut possimus aliquam. Modi ut dolor voluptatum expedita eos. Voluptatem recusandae fugit est voluptatem.
followers : 3102
following : 1780

tiktok:

url : https://tiktok.com/@adam_dev
username : adam_dev
bio : Nemo aut eligendi ea laudantium id natus sit.
followers : 4872
following : 217

instagram:

url : https://instagram.com/wuckert2019
username : wuckert2019
bio : Qui laborum enim qui corporis. Quos quam eaque porro. Occaecati architecto tempora et.
followers : 5498
following : 1322